{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7202,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-d647-710d-b5ca-0193642e1b4c",
      "docSlug": "2344f271f91233184d89da303e5a582f",
      "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides",
      "authorId": "hyperfine",
      "authorName": "Hyperfine",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "roadmap",
      "function": "show_traction",
      "notes": "The slide uses a diagonal timeline layout to represent product evolution.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/15",
      "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c",
      "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 18,
          "from": 12,
          "beatId": "75ac9b1a-2d2a-4255-aa40-a596075f8995",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Traction is presented on pages 12-18, including clinical proof, regulatory excellence, and financial strength.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d647-710d-b5ca-0193642e1b4c",
      "docSlug": "2344f271f91233184d89da303e5a582f",
      "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides",
      "authorId": "hyperfine",
      "authorName": "Hyperfine",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The 2023 figure is marked with an asterisk indicating revenue guidance.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/16",
      "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c",
      "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 18,
          "from": 12,
          "beatId": "75ac9b1a-2d2a-4255-aa40-a596075f8995",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Traction is presented on pages 12-18, including clinical proof, regulatory excellence, and financial strength.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d647-710d-b5ca-0193642e1b4c",
      "docSlug": "2344f271f91233184d89da303e5a582f",
      "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides",
      "authorId": "hyperfine",
      "authorName": "Hyperfine",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart shows a progression from negative margin to positive margin.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/17",
      "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c",
      "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 18,
          "from": 12,
          "beatId": "75ac9b1a-2d2a-4255-aa40-a596075f8995",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Traction is presented on pages 12-18, including clinical proof, regulatory excellence, and financial strength.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d647-710d-b5ca-0193642e1b4c",
      "docSlug": "2344f271f91233184d89da303e5a582f",
      "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides",
      "authorId": "hyperfine",
      "authorName": "Hyperfine",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a bar chart to demonstrate financial discipline and outlines three key areas of investment.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/18",
      "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c",
      "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 18,
          "from": 12,
          "beatId": "75ac9b1a-2d2a-4255-aa40-a596075f8995",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Traction is presented on pages 12-18, including clinical proof, regulatory excellence, and financial strength.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d647-710d-b5ca-0193642e1b4c",
      "docSlug": "2344f271f91233184d89da303e5a582f",
      "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides",
      "authorId": "hyperfine",
      "authorName": "Hyperfine",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "team_bio",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/19",
      "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c",
      "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 19,
          "beatId": "9c7922b1-6808-4aee-8663-141b21fc2f94",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "The leadership team is presented on page 19.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d647-710d-b5ca-0193642e1b4c",
      "docSlug": "2344f271f91233184d89da303e5a582f",
      "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides",
      "authorId": "hyperfine",
      "authorName": "Hyperfine",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/20",
      "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c",
      "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d647-710d-b5ca-0193642e1b4c",
      "docSlug": "2344f271f91233184d89da303e5a582f",
      "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides",
      "authorId": "hyperfine",
      "authorName": "Hyperfine",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/21",
      "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c",
      "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d647-710d-b5ca-0193642e1b4c",
      "docSlug": "2344f271f91233184d89da303e5a582f",
      "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides",
      "authorId": "hyperfine",
      "authorName": "Hyperfine",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "appendix_disclosure",
      "function": "cite_precedent",
      "notes": "The slide serves as a bibliography of peer-reviewed research supporting the company's portable MRI technology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/22",
      "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c",
      "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/CstfTIV4uxy1j3KktI0BFfr4jnw9NCFPvXhDggj0s70/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjk5YmJlNTk0NjdiZTM2M2E5OGQyMWU5OWNiMDc4YS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/1",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "fdd7f9e1-2682-4247-94a2-fdce5088590c",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Attention",
          "beatSlug": "aida-attention",
          "evidence": "The deck starts with a cover slide, disclaimer, and executive summary",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/u2aI1WBtGXJJiM2fRK5VrE5-0SD_S0CHIT6v71hk7CA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjk5YmJlNTk0NjdiZTM2M2E5OGQyMWU5OWNiMDc4YS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/FRTs6cZHP0BVdXyO9ahn0ZsF-XLa8kOWhPaZQJrZ2so/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjk5YmJlNTk0NjdiZTM2M2E5OGQyMWU5OWNiMDc4YS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/8C6cWvU2Xp_lnQ-0esxmRGK6biNWytFR4DboFRUvv_s/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjk5YmJlNTk0NjdiZTM2M2E5OGQyMWU5OWNiMDc4YS9wMDAxLnBuZw"
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/2",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "fdd7f9e1-2682-4247-94a2-fdce5088590c",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Attention",
          "beatSlug": "aida-attention",
          "evidence": "The deck starts with a cover slide, disclaimer, and executive summary",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a numbered list format to present key value propositions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/3",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 3,
          "from": 1,
          "beatId": "fdd7f9e1-2682-4247-94a2-fdce5088590c",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Attention",
          "beatSlug": "aida-attention",
          "evidence": "The deck starts with a cover slide, disclaimer, and executive summary",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "pain_points",
      "function": "frame_problem",
      "notes": "The slide uses a hub-and-spoke diagram to illustrate the central problem of CAR-T neurotoxicity and its four primary negative outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/4",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes a cartoon mascot at the bottom.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/5",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a visual comparison to highlight the safety advantage of NXC-201, specifically focusing on neurotoxicity and CRS duration.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/6",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "Uses a visual icon-grid to represent market expansion from 5% of hospitals to a much broader network.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/7",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "unfair_advantage",
      "function": "present_solution",
      "notes": "The slide uses a molecular biology diagram to illustrate the structural difference in the binding domain of the NXC-201 therapy compared to competitors.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/8",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "product_demo",
      "function": "present_solution",
      "notes": "Includes comparative bar charts and flow cytometry data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/9",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-9",
      "loopMatches": [
        {
          "to": 10,
          "from": 9,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "8d02a94e-79b8-4ba4-920c-87f81d998140",
          "evidence": "The deck presents NXC-201's MoA and clinical highlights",
          "position": 0,
          "objective": "Understanding NXC-201's mechanism of action",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a comparative timeline/chart layout to contrast clinical outcomes of three different therapies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/10",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-10",
      "loopMatches": [
        {
          "to": 10,
          "from": 9,
          "name": "Aha Moment",
          "slug": "03-aha-moment",
          "bestFor": "Data-heavy sections, research findings, analytical arguments",
          "matchId": "8d02a94e-79b8-4ba4-920c-87f81d998140",
          "evidence": "The deck presents NXC-201's MoA and clinical highlights",
          "position": 0,
          "objective": "Understanding NXC-201's mechanism of action",
          "structure": "The Problem/Question -> What the Data Shows -> The Insight",
          "confidence": 0.7,
          "description": "Establish a tension, present data, then deliver the insight that changes everything"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart demonstrates the efficacy of NXC-201 (formerly HBI0101) in clearing diseased cells.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/11",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide uses a process flow diagram to connect cellular pathology to clinical symptoms in the heart, liver, and kidneys.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/12",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "Includes extensive source citations in the footer.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/13",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide uses a table structure to contrast treatment outcomes and patient growth across three stages of multiple myeloma.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/14",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a visual comparison to highlight a 67% improvement in response rates for NXC-201 compared to competitors.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/15",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Includes FDA approval precedents in the footer to establish credibility.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/16",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes detailed clinical trial citations in the footer.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/17",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a two-column layout to separate milestones by drug candidate.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/18",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a side-by-side comparison structure to explain two distinct but complementary technology platforms.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/19",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "roadmap",
      "function": "show_traction",
      "notes": "The table uses a standard pharmaceutical pipeline format, categorizing by clinical vs preclinical status and highlighting specific regulatory and clinical trial milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/20",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "why_now",
      "function": "argue_timing",
      "notes": "Combines market sizing data with a 'Why Now' narrative supported by industry news clippings and a comparative efficacy table.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/21",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-21",
      "loopMatches": [
        {
          "to": 22,
          "from": 21,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "0ad98d72-f65a-494f-a999-cb32332eed00",
          "evidence": "The deck explains NXC-201's market opportunity and potential",
          "position": 1,
          "objective": "Understanding why NXC-201 is entering large markets",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-d6ea-7495-b63c-e64074d45b72",
      "docSlug": "3f99bbe59467be363a98d21e99cb078a",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a wave-like visual to represent market segments and their associated valuations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/22",
      "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72",
      "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-22",
      "loopMatches": [
        {
          "to": 22,
          "from": 21,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "0ad98d72-f65a-494f-a999-cb32332eed00",
          "evidence": "The deck explains NXC-201's market opportunity and potential",
          "position": 1,
          "objective": "Understanding why NXC-201 is entering large markets",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 27,
          "from": 4,
          "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The deck presents the problem, solution, competitive analysis, and traction",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}